Using a diabetic model, we found that recombinant human IL-37 attenuated both atherosclerosis and vascular calcification via regulating the production of osteoprotegerin and inflammatory cytokines such as IL-10, IL-18, TNF-α and IFN-γ17. Here, IL10 is linked to atherosclerosis.